In order to directly test the influence of MDM2 on p53 protein levels and activity in G/G SNP309 cancer cells we constructed MANCA and A875 stable mir30-based mdm2 shRNA knockdown cell lines (Figure 2A). This evidence concerns the gene TP53 and cancer.